“We’re already seeing obviously tremendous strain on the healthcare system right now,” Professor Wendy Parmet, faculty director of Northeastern Law’s Center for Health Policy and Law tells News@Northeastern . “We seem to be at the cusp of what might be the tripledemic.”
Succeeding in trademark suits against the individuals behind Twitter spoof accounts is “not out of the question,” Professor Alexandra Roberts tells Bloomberg Law.
Professor Woodrow Hartzog has been selected to receive Northeastern University's Research and Creative Activity Award in recognition of the prolific body of work he produced in 2020, including several law review articles and a co-authored book titled Breached! Why Data Security Law Fails and How to Improve It.
“While the Commission on Unalienable Rights is officially dead, human rights attorneys and advocates must keep an eye on developments at Notre Dame,” writes Sandy Recinos ’23 who completed her fall co-op with Northeastern Law’s Program on Human Rights and the Global Economy. “No one should be lulled into thinking that the ill-conceived parts of the Unalienable Rights report will simply go away quietly.”
Michael Licker ’10, head of litigation and investigations for Boston-based Wayfair, is profiled by Modern Counsel.
In a co-authored op-ed for CommonWealth, Professor Emily Spieler makes the case in favor of H. 4174/S. 2401, An Act to Protect Injured Workers. The proposed bills would protect workers who seek their rightful access to medical care and workers' compensation from retaliation from their employer.
In her latest piece for the Human Rights at Home Blog, Professor Martha Davis addresses Justice Alito’s dismissal of an equal protection challenge to abortion restrictions.
“This is not a problem of passports and nationality. This is a problem about human beings,” says Professor Wendy Parmet, director of Northeastern Law's Center for Health Policy and Law. “Until the global community sees this as a global problem, that everybody needs to work together in terms of resources and dollars and having a coordinated response, then we’re going to have a problem.”
It’s easy to think of diseases as ‘over there, them, we built a wall—problem solved.’ And that’s just not the way it works, especially with respiratory diseases,” cautions Professor Wendy Parmet, director of Northeastern Law's Center for Health Policy and Law.
“While rainbow fentanyl may dominate the drug news cycle, there are other issues affecting opioid users that need more attention,” says Professor Leo Beletsky, faculty director of Health in Justice Action Lab.